Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Skeletal | 8 | 2024 | 4927 | 1.060 |
Why?
|
Regeneration | 6 | 2024 | 1511 | 0.940 |
Why?
|
Musculoskeletal Physiological Phenomena | 1 | 2023 | 31 | 0.880 |
Why?
|
Satellite Cells, Skeletal Muscle | 1 | 2023 | 126 | 0.810 |
Why?
|
Muscular Diseases | 2 | 2023 | 553 | 0.780 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 37 | 0.730 |
Why?
|
Masks | 1 | 2020 | 208 | 0.600 |
Why?
|
Sarcopenia | 1 | 2021 | 372 | 0.530 |
Why?
|
Wound Healing | 8 | 2024 | 2802 | 0.500 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2023 | 3489 | 0.500 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2023 | 1931 | 0.490 |
Why?
|
Fracture Healing | 5 | 2020 | 445 | 0.480 |
Why?
|
Tissue Scaffolds | 5 | 2024 | 936 | 0.420 |
Why?
|
Osteoblasts | 4 | 2020 | 1143 | 0.380 |
Why?
|
Tissue Engineering | 3 | 2024 | 1872 | 0.310 |
Why?
|
Aging | 3 | 2023 | 8704 | 0.300 |
Why?
|
Extremities | 2 | 2020 | 867 | 0.250 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2023 | 748 | 0.230 |
Why?
|
Glycosaminoglycans | 3 | 2023 | 607 | 0.230 |
Why?
|
Mice | 18 | 2024 | 81474 | 0.220 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5841 | 0.210 |
Why?
|
Replantation | 2 | 2020 | 145 | 0.210 |
Why?
|
Collagen | 5 | 2023 | 2638 | 0.200 |
Why?
|
Porosity | 1 | 2023 | 350 | 0.200 |
Why?
|
MicroRNAs | 5 | 2020 | 3796 | 0.200 |
Why?
|
Urinary Fistula | 1 | 2021 | 42 | 0.190 |
Why?
|
Hydrogels | 3 | 2024 | 721 | 0.190 |
Why?
|
Urethral Diseases | 1 | 2021 | 52 | 0.190 |
Why?
|
Cutaneous Fistula | 1 | 2021 | 79 | 0.180 |
Why?
|
Hypospadias | 1 | 2021 | 97 | 0.180 |
Why?
|
Organ Preservation | 2 | 2020 | 382 | 0.180 |
Why?
|
Animals | 22 | 2024 | 168388 | 0.170 |
Why?
|
Bandages, Hydrocolloid | 1 | 2019 | 8 | 0.170 |
Why?
|
Tennis Elbow | 1 | 2019 | 16 | 0.170 |
Why?
|
Cell Differentiation | 4 | 2022 | 11531 | 0.170 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 131 | 0.170 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 22154 | 0.170 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2020 | 106 | 0.170 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 76 | 0.170 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2022 | 396 | 0.160 |
Why?
|
Guided Tissue Regeneration | 1 | 2019 | 88 | 0.160 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 536 | 0.160 |
Why?
|
Acrylic Resins | 1 | 2019 | 135 | 0.160 |
Why?
|
Nanostructures | 1 | 2024 | 551 | 0.160 |
Why?
|
Urethra | 1 | 2021 | 405 | 0.160 |
Why?
|
Fibrosis | 2 | 2023 | 2048 | 0.160 |
Why?
|
Perfusion | 2 | 2020 | 1374 | 0.160 |
Why?
|
Muscle Development | 1 | 2020 | 259 | 0.160 |
Why?
|
Neuromuscular Junction | 1 | 2021 | 403 | 0.160 |
Why?
|
Bone Resorption | 1 | 2022 | 723 | 0.160 |
Why?
|
Transcriptional Elongation Factors | 1 | 2019 | 164 | 0.160 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 156 | 0.150 |
Why?
|
Fractures, Ununited | 1 | 2020 | 175 | 0.150 |
Why?
|
Chitosan | 1 | 2019 | 131 | 0.150 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2020 | 343 | 0.150 |
Why?
|
Laminin | 1 | 2019 | 407 | 0.150 |
Why?
|
Proteoglycans | 1 | 2019 | 803 | 0.130 |
Why?
|
Femoral Fractures | 1 | 2020 | 375 | 0.130 |
Why?
|
Urinary Bladder | 1 | 2022 | 1150 | 0.130 |
Why?
|
Veins | 1 | 2020 | 768 | 0.130 |
Why?
|
Wnt Proteins | 1 | 2019 | 718 | 0.130 |
Why?
|
Exosomes | 1 | 2019 | 423 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 559 | 0.120 |
Why?
|
Metformin | 1 | 2022 | 907 | 0.120 |
Why?
|
Interleukin-10 | 1 | 2019 | 1175 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2020 | 11900 | 0.110 |
Why?
|
Osteogenesis | 1 | 2019 | 1273 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1861 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.100 |
Why?
|
Lower Extremity | 1 | 2020 | 1201 | 0.100 |
Why?
|
Mammaplasty | 1 | 2021 | 1239 | 0.090 |
Why?
|
Signal Transduction | 3 | 2023 | 23427 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8635 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2020 | 2221 | 0.090 |
Why?
|
Fibroblasts | 1 | 2019 | 4139 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7582 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2021 | 2490 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2021 | 15647 | 0.070 |
Why?
|
Fractures, Bone | 1 | 2019 | 2046 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2021 | 4063 | 0.070 |
Why?
|
Swine | 3 | 2022 | 5915 | 0.070 |
Why?
|
Cell Line | 1 | 2020 | 15599 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18234 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8527 | 0.060 |
Why?
|
E2F1 Transcription Factor | 1 | 2022 | 178 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10203 | 0.050 |
Why?
|
Polyesters | 1 | 2024 | 374 | 0.050 |
Why?
|
Humans | 16 | 2024 | 761326 | 0.050 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2021 | 78 | 0.050 |
Why?
|
RANK Ligand | 1 | 2022 | 318 | 0.050 |
Why?
|
Warm Ischemia | 1 | 2020 | 58 | 0.040 |
Why?
|
Organ Preservation Solutions | 1 | 2020 | 100 | 0.040 |
Why?
|
Adhesiveness | 1 | 2019 | 52 | 0.040 |
Why?
|
Biology | 1 | 2022 | 289 | 0.040 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2021 | 278 | 0.040 |
Why?
|
Esthetics | 1 | 2021 | 330 | 0.040 |
Why?
|
Osteoclasts | 1 | 2022 | 711 | 0.040 |
Why?
|
Stromal Cells | 1 | 2024 | 1330 | 0.040 |
Why?
|
3T3 Cells | 1 | 2019 | 1084 | 0.040 |
Why?
|
Arm | 1 | 2021 | 590 | 0.040 |
Why?
|
Ultrasonic Therapy | 1 | 2019 | 215 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 1 | 2019 | 378 | 0.040 |
Why?
|
Cold Temperature | 1 | 2020 | 786 | 0.030 |
Why?
|
Neurogenesis | 1 | 2023 | 862 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2020 | 983 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 1405 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2021 | 2115 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12144 | 0.030 |
Why?
|
Muscle Strength | 1 | 2019 | 624 | 0.030 |
Why?
|
Arteries | 1 | 2020 | 1125 | 0.030 |
Why?
|
Autophagy | 1 | 2022 | 1321 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2252 | 0.030 |
Why?
|
Antifungal Agents | 1 | 2019 | 752 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2020 | 10431 | 0.030 |
Why?
|
Apoptosis | 2 | 2020 | 9474 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2021 | 1344 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2048 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 2913 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2023 | 8166 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22124 | 0.020 |
Why?
|
Breast | 1 | 2021 | 1966 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1741 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2022 | 3082 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3108 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2977 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9319 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5768 | 0.020 |
Why?
|
Male | 6 | 2021 | 360621 | 0.020 |
Why?
|
Rats | 1 | 2023 | 23729 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7390 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9414 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18962 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 64645 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 80575 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18401 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7439 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36202 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42251 | 0.010 |
Why?
|
Female | 3 | 2022 | 392485 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29588 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39108 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54405 | 0.010 |
Why?
|
Middle Aged | 1 | 2020 | 220774 | 0.000 |
Why?
|
Aged | 1 | 2018 | 169179 | 0.000 |
Why?
|
Adult | 1 | 2020 | 221122 | 0.000 |
Why?
|
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_